SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-029582
Filing Date
2024-04-03
Accepted
2024-04-03 07:40:57
Documents
15
Period of Report
2024-04-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203239-8k_biomx.htm   iXBRL 8-K 26992
2 PRESS RELEASE DATED APRIL 3, 2024 ea020323901ex99-1_biomx.htm EX-99.1 76593
  Complete submission text file 0001213900-24-029582.txt   335878

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20240403.xsd EX-101.SCH 3919
4 XBRL DEFINITION FILE phge-20240403_def.xml EX-101.DEF 26852
5 XBRL LABEL FILE phge-20240403_lab.xml EX-101.LAB 37192
6 XBRL PRESENTATION FILE phge-20240403_pre.xml EX-101.PRE 25476
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0203239-8k_biomx_htm.xml XML 6078
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 24816866
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)